Budesonide Extended-Release Tablets — Class II drug recall D-0276-2024
Terminated recall by Golden State Medical Supply Inc., reported 2024-02-07, distributed in IL. Failed Dissolution Specifications
| Recall number | D-0276-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2024-01-12 |
| Classified | 2024-01-29 |
| Reported by FDA | 2024-02-07 |
| Terminated | 2025-03-20 |
| Distributed | IL |
| Quantity | 108 bottles |
| Reason classes | specification failure |
| NDC | 51407-0824-30 |
| Lot numbers | GS054862 |
| Expiration dates | 2025-07-31 |
Product
Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0276-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.